Our research philosophy

Pelago is dedicated to delivering safe and effective care for our members. In order to do so we turn to science, conducting research and peer-reviewed studies. Substance use disorders can be treated in a variety of ways, including social support, therapy, medication or a combination of treatments. But what is the most effective? Through rigorous research, we validate and refine our treatment approaches, leveraging outcomes of scientific inquiry to guide custom solutions for each individual who participates in our programs.

We’ve found some interesting results so far and we encourage you to take a look at the data yourself.


biochemically-verified quit rate at 28 days


biochemically verified quit rate at 26 weeks post-quit date


more likely to remain abstinent from tobacco at 12 months

05/29/2024Monico et al. / Digital Health

Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder

Number of Abstinent Days (past 30)

0 Days
1-10 Days
11-20 Days
21-29 Days
30 Days


abstinent over 90 days


average medication adherence

overall decrease in depression & anxiety

overall increase in well-being

09/09/2023Glasner et al. / Springer

Implementing Suicide Risk Screening in a Virtual Addiction Clinic

Virtual Suicide Research Screening


Screened patients


Screen-positive rate


of clinicians were comfortable asking patients about suicidal thoughts and behaviors

04/19/2023Webb et al. / Liebert

Feasibility and Preliminary Outcomes of a Mobile Intervention Combining Cognitive Behavioral Therapy, Virtual Coaching, and Nicotine Replacement Therapy for Nicotine Vaping Cessation


of participants quit vaping

time vaping decreased from 75.8 minutes to 26.5 minutes

days vaping decreased from 24.7 to 3.9

11/04/2022Glasner et al. / Liebert

Feasibility, Acceptability, and Preliminary Outcomes of an Integrated Telemedicine Intervention Combining Naltrexone and Cognitive Behavioral Therapy for Alcohol Use Disorder

Changes in mean percentage of days abstinent

Days Abstinent


of participants reduced their alcohol use

drinks per day decreased from 6.7 to 2.7


participation and satisfaction

04/26/2022Webb et al. / Oxford Academic

Long-term effectiveness of a digital, clinician-assisted CBT intervention for smoking cessation: a randomized clinical trial.

7-day point prevalence quit rates

Face-to-face Support


more likely to self-report 7-day abstinence with Pelago than traditional care

self-reported smoking abstinence was significantly higher with Pelago participants

Week 26

saw larger increases in self-efficacy observed among Pelago participants

Say hello to brighter days together

Get started quickly. Reduce healthcare spend. Change lives forever.